Page last updated: 2024-11-06

ck 0569 a

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

guanidino propyl piperazine: anti-plaque agent; RN given refers to dimethanesulfonate; structure given in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID50288
MeSH IDM0087236

Synonyms (26)

Synonym
ipexidine mesylate
D04602
69017-90-9
ipexidine mesylate (usan)
urea, n,n'-(1,4-piperazinediylbis(3,1-propanediyliminocarbonimidoyl)bis(n'-hexyl-, dimethanesulfonate
urea, n,n''-(1,4-piperazinediylbis(3,1-propanediyliminocarbonimidoyl)bis(n'-hexyl-, dimethanesulfonate
ci8ct0864p ,
cko 569a
1,4-bis(3-(n-hexylcarbamylguanidino)propyl)piperazine dimethanesulfonic acid
ck 0569 a
ck-0569 [as the base]
1,1'-(1,4-piperazinediylbis(trimethyleneiminoimidocarbonyl))bis(3-hexylurea) dimethanesulfonate
ipexidine mesylate [usan:inn]
unii-ci8ct0864p
guanidino propyl piperazine
ipexidine mesilate
ck-0569a
ck-569a
urea, n,n''-(1,4-piperazinediylbis(3,1-propanediyliminocarbonimidoyl)bis(n'-hexyl-, dimethanesulphonate
ck-0569 mesylate
ipexidine mesylate [usan]
1,1'-(1,4-piperazinediylbis(trimethyleneiminoimidocarbonyl))bis(3-hexylurea) dimethanesulphonate
methanesulfonic acid--n,n''-{piperazine-1,4-diylbis[(propane-3,1-diyl)carbamimidoyl]}bis(n'-hexylcarbamimidic acid) (2/1)
DTXSID80988771
Q27275478
1-[n'-[3-[4-[3-[[amino-(hexylcarbamoylamino)methylidene]amino]propyl]piperazin-1-yl]propyl]carbamimidoyl]-3-hexylurea;methanesulfonic acid
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (5)

TimeframeStudies, This Drug (%)All Drugs %
pre-19905 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 12.50

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index12.50 (24.57)
Research Supply Index1.95 (2.92)
Research Growth Index4.45 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (12.50)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials1 (20.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other4 (80.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]